Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helfand

Showing results (581-590 of 657) with videos related to

Pageof 66
Sort By:
Journal of Clinical Epidemiology|August 2, 2011
GRADE guidelines: 8. Rating the quality of evidence--indirectnessGordon H Guyatt, Andrew D Oxman, Regina Kunz, et al.
Plos One|October 8, 2011
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrenceQiang Zhang, Lin Chen, Brian T Helfand, et al.
Research and Practice in Thrombosis and Haemostasis|June 11, 2025
Development and validation of a genetic probability for venous thromboembolismZhuqing Shi, Ashley J Mulford, Huy Tran, et al.
The Prostate|March 10, 2018
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancerYishuo Wu, Hongjie Yu, S Lilly Zheng, et al.
Cancer Gene Therapy|August 29, 2003
Enhancing antimelanoma immune responses through apoptosisStacie R Bianco, Juan Sun, Susan P Fosmire, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Clinical issues and research in respiratory failure from severe acute respiratory syndromeMitchell M Levy, Melisse S Baylor, Gordon R Bernard, et al.
American Journal of Clinical Pathology|January 22, 2025
Bridging the gap: Evaluating ChatGPT-generated, personalized, patient-centered prostate biopsy reportsErin S Proctor, David J Nusbaum, John M Lee, et al.
The Prostate|May 23, 2025
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN GuidelinesJianfeng Xu, Jim Lu, Marta Gielzak, et al.
The Prostate|July 26, 2018
Germline mutations in PPFIBP2 are associated with lethal prostate cancerYishuo Wu, Hongjie Yu, Siqun Lilly Zheng, et al.
Circulation. Genomic and Precision Medicine|April 10, 2026
Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care BiobankJianfeng Xu, Zhuqing Shi, Sumeet A Khetarpal, et al.
Pageof 66

Showing results (581-590 of 657) with videos related to

Sort By:
Pageof 66
Journal of Clinical Epidemiology|August 2, 2011
GRADE guidelines: 8. Rating the quality of evidence--indirectnessGordon H Guyatt, Andrew D Oxman, Regina Kunz, et al.
Plos One|October 8, 2011
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrenceQiang Zhang, Lin Chen, Brian T Helfand, et al.
Research and Practice in Thrombosis and Haemostasis|June 11, 2025
Development and validation of a genetic probability for venous thromboembolismZhuqing Shi, Ashley J Mulford, Huy Tran, et al.
The Prostate|March 10, 2018
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancerYishuo Wu, Hongjie Yu, S Lilly Zheng, et al.
Cancer Gene Therapy|August 29, 2003
Enhancing antimelanoma immune responses through apoptosisStacie R Bianco, Juan Sun, Susan P Fosmire, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Clinical issues and research in respiratory failure from severe acute respiratory syndromeMitchell M Levy, Melisse S Baylor, Gordon R Bernard, et al.
American Journal of Clinical Pathology|January 22, 2025
Bridging the gap: Evaluating ChatGPT-generated, personalized, patient-centered prostate biopsy reportsErin S Proctor, David J Nusbaum, John M Lee, et al.
The Prostate|May 23, 2025
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN GuidelinesJianfeng Xu, Jim Lu, Marta Gielzak, et al.
The Prostate|July 26, 2018
Germline mutations in PPFIBP2 are associated with lethal prostate cancerYishuo Wu, Hongjie Yu, Siqun Lilly Zheng, et al.
Circulation. Genomic and Precision Medicine|April 10, 2026
Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care BiobankJianfeng Xu, Zhuqing Shi, Sumeet A Khetarpal, et al.
Pageof 66